Cargando…

Early Measles Vaccination During an Outbreak in the Netherlands: Short-Term and Long-Term Decreases in Antibody Responses Among Children Vaccinated Before 12 Months of Age

BACKGROUND: The majority of infants will not be protected by maternal antibodies until their first measles vaccination, between 12 and 15 months of age. This provides incentive to reduce the age at measles vaccination, but immunological consequences are insufficiently understood, and long-term effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brinkman, Iris D, de Wit, Jelle, Smits, Gaby P, ten Hulscher, Hinke I, Jongerius, Maria C, Abreu, Taymara C, van der Klis, Fiona R M, Hahné, Susan J M, Koopmans, Marion P G, Rots, Nynke Y, van Baarle, Debbie, van Binnendijk, Robert S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639599/ https://www.ncbi.nlm.nih.gov/pubmed/30972418 http://dx.doi.org/10.1093/infdis/jiz159

Ejemplares similares

Measles Vaccination Elicits a Polyfunctional Antibody Response, Which Decays More Rapidly in Early Vaccinated Children
por: Brinkman, Iris D, et al.
Publicado: (2021)

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults
por: Kaaijk, Patricia, et al.
Publicado: (2022)

Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks
por: Smits, Gaby, et al.
Publicado: (2013)

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands
por: Hoes, Joske, et al.
Publicado: (2018)

Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles
por: Woudenberg, Tom, et al.
Publicado: (2019)

Short- and long-term impact of vaccination against cytomegalovirus: a modeling study
por: Rozhnova, Ganna, et al.
Publicado: (2020)

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
por: Sane, Jussi, et al.
Publicado: (2014)

Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010)

Measles outbreak in a community with very low vaccine coverage, the Netherlands.
por: van den Hof, S, et al.
Publicado: (2001)

Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose
por: Kaaijk, Patricia, et al.
Publicado: (2020)

Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands
por: Vos, Regnerus A., et al.
Publicado: (2019)

Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019)

Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic
por: Kaaijk, Patricia, et al.
Publicado: (2015)

Effect of vaccination on severity and infectiousness of measles during an outbreak in the Netherlands, 2013–2014
por: van Dam, A.S.G., et al.
Publicado: (2020)

Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014
por: van der Maas, Nicoline A. T., et al.
Publicado: (2016)

Identification of aging‐associated immunotypes and immune stability as indicators of post‐vaccination immune activation
por: Cevirgel, Alper, et al.
Publicado: (2022)

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
por: Tielemans, Susanne M A J, et al.
Publicado: (2017)

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
por: Woudenberg, Tom, et al.
Publicado: (2017)

Publisher Correction: Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence
por: den Hartog, Gerco, et al.
Publicado: (2020)

Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019)

Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students
por: Gouma, Sigrid, et al.
Publicado: (2014)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
por: Kaaijk, Patricia, et al.
Publicado: (2012)

BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial
por: Claus, Juana, et al.
Publicado: (2023)

Lower Transplacental Antibody Transport for Measles, Mumps, Rubella and Varicella Zoster in Very Preterm Infants
por: van den Berg, Jolice P., et al.
Publicado: (2014)

Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals
por: Emmelot, Maarten E., et al.
Publicado: (2022)

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant
por: Kho, Marcia M L, et al.
Publicado: (2021)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Mumps Vaccine Effectiveness Against Orchitis
por: Hahné, Susan, et al.
Publicado: (2012)

Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study
por: Swart, E. M., et al.
Publicado: (2016)

Vaccination against RSV: Is maternal vaccination a good alternative to other approaches?
por: Kaaijk, Patricia, et al.
Publicado: (2013)

Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization
por: Verheul, Marije K., et al.
Publicado: (2023)

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
por: van den Hoogen, Lotus L., et al.
Publicado: (2022)

Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study
por: Bianchi, Francesco Paolo, et al.
Publicado: (2020)

Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands
por: Vissers, Marloes, et al.
Publicado: (2018)

The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness – A systematic review
por: Hughes, Stephanie L., et al.
Publicado: (2020)

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Sanders, Jan-Stephan F, et al.
Publicado: (2022)

Editorial: Role of HLA and KIR in Viral Infections
por: de Wit, Jelle, et al.
Publicado: (2016)

Effect of early two-dose measles vaccination on childhood mortality and modification by maternal measles antibody in Guinea-Bissau, West Africa: A single-centre open-label randomised controlled trial
por: Nielsen, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ebfcfmsairv2pmovgvl7r5kb9n